The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease

Table 1

Association of anti-GP2 IgA and/or IgG with location of disease in CD.

P = 0.002	Anti-GP2 IgA/IgG
	Positive	Negative	Total
Ileocolonic location
Positive	11	5	16
Negative	4	19	23
Total	15	24	39

Investigating the association of anti-GP2 IgA/IgG with different clinical phenotypes in CD, 11/16 of CD patients with ileocolonic location demonstrated anti-GP2 antibody positivity (P = 0.002).